We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

110 hedge funds and large institutions have $141M invested in Surgalign Holdings, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

1% less funds holding

Funds holding: 111110 (-1)

6% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 36

15% less capital invested

Capital invested by funds: $166M → $141M (-$25M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $7K

Holders
110
Holders Change
-1
Holders Change %
-0.9%
% of All Funds
2.93%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
11
Increased
34
Reduced
36
Closed
11
Calls
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$8K
Name Holding Trade Value Shares
Change
Change in
Stake
NI
51
Numeric Investors
Massachusetts
$210K -$4.11K -41 -2%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$208K +$15.9K +159 +8%
TA
53
Teton Advisors
New York
$207K
MC
54
Menta Capital
California
$196K +$209K +2,088 New
BG
55
BlackRock Group
United Kingdom
$193K
AQR Capital Management
56
AQR Capital Management
Connecticut
$189K -$348K -3,472 -63%
AllianceBernstein
57
AllianceBernstein
Tennessee
$185K
Axa
58
Axa
France
$181K -$10K -100 -5%
BCCM
59
Blue Clay Capital Management
Minnesota
$168K -$104K -1,033 -37%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$163K
PCM
61
Prelude Capital Management
New York
$150K +$11.3K +113 +8%
PAM
62
Panagora Asset Management
Massachusetts
$150K +$68.1K +679 +73%
Manulife (Manufacturers Life Insurance)
63
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$135K -$10.7K -107 -7%
TC
64
TFS Capital
Pennsylvania
$128K -$735K -7,331 -84%
SRC
65
Shufro Rose & Co
New York
$121K
Goldman Sachs
66
Goldman Sachs
New York
$118K -$9.32K -93 -7%
Federated Hermes
67
Federated Hermes
Pennsylvania
$116K -$902 -9 -0.7%
Bank of America
68
Bank of America
North Carolina
$107K +$28.3K +282 +33%
AIG
69
American International Group
New York
$104K +$100 +1 +0.1%
BCM
70
Bridgeway Capital Management
Texas
$102K +$109K +1,087 New
Ameriprise
71
Ameriprise
Minnesota
$92K +$97.8K +976 New
PTC
72
Petrus Trust Company
Texas
$81K -$4.71K -47 -5%
Jacobs Levy Equity Management
73
Jacobs Levy Equity Management
New Jersey
$80K +$25.8K +257 +44%
Wells Fargo
74
Wells Fargo
California
$79K -$245K -2,440 -74%
VKH
75
Virtu KCG Holdings
New York
$78K -$17.7K -177 -18%

SRGA Hedge Fund Activity: Q3 2016 in Review

110 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2016, worth a combined $141M — down 15% from $166M a quarter earlier.

Fund positioning in SRGA was balanced in Q3 2016: 11 funds opened new positions, 11 closed out, 34 added to existing stakes and 36 trimmed.

The largest buyer was Krensavage Asset Management, adding an estimated $1.78M. The largest seller was Kopp Investment Advisors, cutting an estimated $1.99M.

  • 110 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2016, down from 111 in Q2 2016.
  • Funds reported $141M of Surgalign Holdings, Inc. Common Stock stock for Q3 2016, down 15% quarter-over-quarter.
  • 11 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2016 and 11 closed out, a net change of 0 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2016 was Krensavage Asset Management, an estimated $1.78M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2016 was Kopp Investment Advisors, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2016.